Calcium N5-methyltetrahydrofolate

CAS No. 26560-38-3

Calcium N5-methyltetrahydrofolate( NSC-173328 )

Catalog No. M13814 CAS No. 26560-38-3

The calcium salt of levomefolic acid that has been proposed for treatment of cardiovascular disease and advanced cancers such as breast and colorectal cancers.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 85 In Stock
10MG 140 In Stock
25MG 250 In Stock
50MG 361 In Stock
100MG 500 In Stock
200MG 712 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Calcium N5-methyltetrahydrofolate
  • Note
    Research use only, not for human use.
  • Brief Description
    The calcium salt of levomefolic acid that has been proposed for treatment of cardiovascular disease and advanced cancers such as breast and colorectal cancers.
  • Description
    The calcium salt of levomefolic acid that has been proposed for treatment of cardiovascular disease and advanced cancers such as breast and colorectal cancers.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    NSC-173328
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    Antifolate
  • Recptor
    Antifolate
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    26560-38-3
  • Formula Weight
    497.5179
  • Molecular Formula
    C20H23CaN7O6
  • Purity
    >98% (HPLC)
  • Solubility
    10 mM in DMSO
  • SMILES
    O=C(O)CC[C@@H](C([O-])=O)NC(C1=CC=C(NCC2N(C)C3=C(NC(N)=NC3=O)NC2)C=C1)=O.[Ca+2]
  • Chemical Name
    L-Glutamic acid, N-[4-[[(2-amino-3,4,5,6,7,8-hexahydro-5-methyl-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-, calcium salt (1:1)

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • LSN 3213128

    LSN 3213128 is a novel potent, selective and orally-bioavailable antifolate with potent and specific inhibitory activity for AICARFT.

  • Farletuzumab

    Farletuzumab (MORAb-003) is a humanized monoclonal antibody with a high affinity for folate receptor-α (FRα), acting as a potent inhibitor of FRα and impeding the growth of cells that overexpress this receptor, making it useful for cancer research.

  • Aminopterin

    Aminopterin is a synthetic folic acid derivative whose metabolite is a competitive inhibitor of dihydrofolate reductase.